1. Hepatocellular carcinoma

2. Viral hepatitis

3. Alcoholic and nonalcoholic liver disease

4. Liver cirrhosis and complications

1. New diagnostic approach to overcome chicago 3.0

2. Interventional therapheutic approach

3. Achalasia seoul consensus

4. Beyond Chicago 3.0 and Toward Chicago 4.0

5. Discussion

1. Current status of Artificial Intelligence in medicine

2. Artificial intelligence in endoscopy: Methods

3. How to start AI research as a clinician?

4. Basic concept and technique for medical AI development

5. Discussion

• Evolution of intraarterial therapy for hepatocellular carcinoma

1. Pathophysiology

2. Postinfection IBS

3. Medical approach

4. Novel approach of IBS

5. Discussion

1. Imaging differention of pancreatic cystic neoplasm

2. EUS differentiation of pancreatic cystic neoplasm

3. Treatment strategy for pancreatic cystic neoplasm: Gastroenterologists' view

4. Treatment strategy for pancreatic cystic neoplasm: Surgeons' view

5. Case-based Discussion

6. Discussion

1. Application of deep learning in upper gastrointestinal diseases

2. Deep learning-based prediction model development for liver diseases

3. Deep learning analysis for the diagnosis of neoplastic polyp in gallbladder polypoid lesions

4. Prediction and diagnosis for colorectal neoplasm using artificial intelligence

5. Discussion

FP-07-01  /  Association between TyG index and gastric carcinogenesis: a health checkup cohort study

FP-07-02  /  LGR5-specific water-soluble peptide probe for detection of gastric cancers

FP-07-03  /  Clinicopathological significance of TP53 mutation by p53 immunohistochemistry in gastric cancer

FP-07-04  /  TGF-β-induced miR-181b-5p expression promotes epithelial-to-mesenchymal transition in human pancreatic cancer

FP-07-05  /  FOLFIRINOX versus Gemcitabine with nab-Paclitaxel in metastatic pancreatic cancer: A systematic review and meta-analysis

FP-07-06  /  Real world experiences on sequential therapies in patients with metastatic pancreatic adenocarcinoma

1. Manufacture of iPS cell and clinical application

2. Application of Next generation sequencing

3. Adopting artificial inteligence

4. Establishment of liver organoids

1. Pathologic spectrum of gastric MALT lymphoma

2. Treatment of gastric MALT lymphoma: Helicobacter pylori eradication

3. Treatment of gastric MALT lymphoma: Beyond the eradication

4. New perspectives in gastric MALT lymphoma

5. Discussion

1. EUS-guided pain management

2. EUS-guided choledochoduodenostomy vs. hepaticogastrostomy in malignant distal biliary obstruction

3. EUS-guided ablation therapy for pancreatic/peripancreatic tumors (cystic lesion?)

4. EUS-guided tissue acquisition for bile duct cancer (including hilar cholangiocarcinoma)

5. Discussion

1. Artificial intelligence for the diagnosis of gastric cancer

2. AI in GI tract pathology

3. Application of deep learning in liver radiology

4. Deep learning techniques for reduced radiation dose of abdominal CT

5. Discussion

PS-07-01  /  Epidermal growth factor (EGF)-based activatable probe for predicting therapeutic outcome of an EGF-based doxorubicin prodrug

PS-07-02  /  Different effect of p53 protein overexpression on the survival of gastric cancer according to Lauren classification: retrospective study

PS-07-03  /  Tumor budding is important to predict lymph node metastasis in early gastric cancer

PS-07-04  /  Prognostic factors in patients receiving pembrolizumab with biliary tract cancer

PS-07-05  /  Gemcitabine plus nab-paclitaxel for second-line therapy of pancreatic cancer: a phase II, single-arm, multicenter study

PS-07-06  /  Real world experiences on Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers

PS-04-01  /  Probe-based confocal laser endomicroscopy was superior than white light endoscopy with NBI in predicting and collecting residual cancer tissues in patients with gastric cancer on chemotherapy

PS-04-02  /  Evaluation of Clinical Usefulness of LCI At The Diagnosis EGC and Gastric Dysplasia Based By Color Contrast

PS-04-03  /  Endoscopic and histologic improvement of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication

PS-04-04  /  Effect of drinking warm water on esophageal preparation before peroral endoscopic myotomy in achalasia patients: A pilot study

PS-04-05  /  Clinical outcome and Safety of POEM between First Treatment and Treatment Failure in Achalasia patients.

PS-04-06  /  Predictive value of esophageal functional luminal imaging probe(FLIP) panometry in patients with achalasia undergoing peroral endoscopic myotomy: a single-center experience

1. Autoimmune hepatitis

2. Primary biliary cholangitis

3. Wilson's disease

4. Vascular liver disease

1. Cost effectiveness of gastric cancer screening in Korea

2. Clinical benefit of endoscopic screening in gastric cancer

3. The value of serologic tests in gastric cancer screening

4. Gastric cancer screening stratification by race and ethnicity

5. Discussion

1. Esophageal/stomach cancer

2. Colorectal cancer

3. Pancreatic cancer

4. Gastroenteropancreatic neuroendocrine tumor (GEP-NET)

5. Discussion

1. Application of deep learning in capsule endoscopy

2. Gastrointestinal endoscopic image analysis using AI: Current status and future perspective

3. Risk Prediction for Pancreatic Fistula after Pancreatoduodenectomy using Artificial Intelligence

4. The development of biomarker for hepatocellular carcinoma through AI

5. Discussion

PS-03-01  /  Should small gastric subepithelial tumors measuring ≤2 cm undergo endoscopic resection?

PS-03-02  /  Underwater endoscopic mucosal resection for upper gastrointestinal submucosal tumor

PS-03-03  /  Long-term outcomes and prognostic factors of endoscopic submucosal dissection for early gastric cancer in elderly patients aged ≥ 80 years

PS-03-04  /  Long-term outcomes and prognostic factors of endoscopic submucosal dissection for early gastric cancer in patients aged ≥75 years

PS-03-05  /  Risk of metachronous gastric neoplasm after endoscopic submucosal dissection: a comparison between undifferentiated type and differentiated type

PS-03-06  /  Long term safety and efficacy of etomidate in comparison with propofol only as sedative for gastric endoscopic submucosal dissection: a prospective, single-center, randomized, double-blind study

1. Intractable ascites in cirrhotic patients

2. DAA treatment-failure in chronic hepatitis C

3. First-line systemic treatment failure in HCC

4. NAFLD patients failing life-style modification

1. Nutritional assessment in patients with gastrointestinal disease

2. Enteral routes for the patients with gastrointestinal diseases

3. Parenteral routes for the patients with gastrointestinal diseases

4. Nutritional support in patients with gastrointestinal disease

5. Discussion

1. Definition of resectability and rationale of neoadjuvant therapy for pancreatic cancer

2. Neoadjuvant therapy vs. Upfront surgery in resectable pancreatic cancer 

3. Neoadjuvant chemotherapy vs. chemoradiotherapy in borderline resectable and locally advanced pancreatic cancer:

4. Strategy of conversion surgery for unresectable pancreatic cancer

5. Discussion

PS-06-01  /  Comparative Study of Narrow-band Imaging versus i-scan for the Prediction of Histology in Intermediate-to-Large Colorectal Polyps: A Prospective, Randomized Pilot Study

PS-06-02  /  Comparison Between 1-L PEG and 2L of Polyethylene Glycol as a Split Dose Bowel Preparation for colonoscopy: A prospective, single-center, noninferiority, randomized controlled trial

PS-06-03  /  Comparative evaluation of the efficacy of oral sulfate solution and 2L polyethylene glycol with ascorbic acid for bowel preparation of elderly people (multi-center, prospective randomized comparative trial)

PS-06-04  /  Long-term outcomes of early colorectal cancer treated by endoscopic submucosal dissection: Multicenter retrospective study.

PS-06-05  /  Stent as bridge to surgery for malignant colonic obstruction : long term outcome

1. Obesity, metabolic disease, and NAFLD

2. Obesity and GI cancer

3. Endoscopic Approach to Obesity and metabolic disroder

4. Surgical options for management of obesity and metabolic disease: What is new?

5. Discussion

1. Precision medicine for GI cancer: from genomics to in vivo model

2. Personalized medicine in functional gastrointestinal disorders

3. Precision medicine for choosing ideal drugs in IBD

4. Disease models using organoids for precision medicine

5. Discussion

1. Epidemiological change of HCC

2. Pathologist's role in the precision medicine for HCC

3. Combination treatment with locoregional and systemic treatments for advanced HCC in the era of immunooncologics

4. Current systemic therapy options for HCC

1. Establishment of patient-derived exvivo model for pancreatobiliary cancer

2. Proteogenomics-based classification in cholangiocarcinoma

3. Microbiome environment in patients with biliary tract cancer

4. Tumor microenvironment study using pancreatic cancer slice cultures

5. Discussion

1. Review of current practice guidelines for nutritional management

2. Monitoring to prevent the complications in nutritional support

3. Smarter management of anemia in IBD

4. Nutritional challenges in critically ill patients

5. Discussion

FP-05-01  /  Comparison of Surepath Liquid Based Cytology and Conventional Smear in Diagnosing Biliary Tract Cancer: A Retrospective Study Using Inverse Probability Weighting Analysis

FP-05-02  /  Direct per-oral cholangioscopy using multibending ultra-slim endoscope through a lumen-apposing metal stent after EUS-guided choledochoduodenostomy; a feasibility study

FP-05-03  /  Outcomes of rescue endoscopic retrograde cholangiopancreatography in patients with failed cannulation at an initial endoscopic retrograde cholangiopancreatography

FP-05-04  /  Comparison of success and complication rate of ERCP after endoscopist move from a tertiary hospital to a secondary hospital

FP-05-05  /  Effectiveness of EUS-guided drainage using novel lumen-apposing metal stent for peripancreatic fluid collection: Single center experience

1. PPI Use and Dementia Risk: yes or no

2. Antiviral therapy for prevention of HCC: Tenofovir vs Entecavir

3. CRC screening: Age issue

4. Discussion

1. What is proteogenomics? - Concepts, Methods, and Tools

2. An Accessible Proteogenomics Informatics Resource

3. Proteogenomics approaches to discover biomarker in IBD

4. Integrating proteomics and genomics in cancer biology

5. Discussion

1. Recent advances toward the cure of chronic hepatitis B

2. MAFLD as emerging concept of NAFLD

3. Risk of HCC in DAA-treated CHC patients

4. Emerging treatment for NASH

1. Current options of chemotherapy for biliary tract cancer

2. Emerging molecular targets and biomarkers in biliary tract cancer

3. Global clinical update in biliary tract cancer

4. Up-to-date endoscopic management of biliary tract cancer

5. Discussion

FP-06-01  /  Early prognostic factors of severe lower gastrointestinal bleeding; retrospective study

FP-06-02  /  Risk Factor Of Colonic Diverticular Bleeding

FP-06-03  /  Comparison of 4L polyethylene glycol and 2L polyethylene glycol plus ascorbic acid in elderly patients aged 60-79:a prospective randomized study

FP-06-04  /  Effective growth inhibition of Clostridium difficile by intestinal isolates(live form bacteria and cell-free supernatant)from human feces

FP-06-05  /  Improvement of Three-Dimensional Colonoscope Image Reconstruction using Fiber Brag Grating Sensor

FP-03-01  /  Impact of Metabolic Unhealthiness and Its changes on the Risk of Erosive esophagitis: A cohort study

FP-03-02  /  Machine learning approach for differentiating cytomegalovirus esophagitis from herpes simplex virus esophagitis

FP-03-03  /  Rebamipide for the Improvement of Gastric Atrophy and Intestinal Metaplasia: A Prospective, Randomized, Double-Blind Study

FP-03-04  /  HOTAIR induced methylation of PCDH10, tumor suppressor gene, by regulating DNMT1 and sponging with miR-148b in gastric adenocarcinoma

1. Understanding stem cells and its medical application

2. Organoid on a chip for GI model

3. Mesenchymal Stem Cell: from basic to clinical application

4. Clinical Application of Organoids for Tissue Regeneration

5. Discussion

1. Role of microbiome in Immune system

2. Microbiome in gastrointestinal cancer

3. Microbiome modulation in liver disease

4. Discussion

1. Current strategy for optimal selection of antiviral therapy for CHB

2. Current algorithm for the assessment of NAFLD

3. Recent guidelines on nutrition in cirrhosis

4. Treatment for advanced HCC: current standard and future

FP-08-01  /  A preliminary study of bile microbiota in patients with pigment common bile duct stone

FP-08-02  /  Outcomes of Patients with Hilar Cholangiocarcinoma Undergoing Preoperative Right Portal Vein Embolization

FP-08-03  /  Mass spectrometry-based protein profiling of circulating exosomes for predicting the prognosis of intraductal pancreatic mucinous neoplasms

FP-08-04  /  Serial Circulating Tumor DNA Monitoring to Evaluate Treatment Response in Metastatic Pancreatic Cancer

FP-08-05  /  Endoscopic versus surgical intervention for painful obstructive chronic pancreatitis: A systematic review and meta-analysis

PS-05-01  /  Efficacy and safety of temperature-controlled radiofrequency ablation in advanced malignant hilar biliary obstruction: A multicenter randomized comparative trial

PS-05-02  /  The effectiveness of High flow nasal cannula in patients who underwent ERCP under sedation

PS-05-03  /  Development of a New Ablation Therapy Using Endoscopic Irreversible Electroporation in Bile Duct

PS-05-04  /  Combination of Endoscopic Ultrasonography-guided Fine Needle Aspiration and Endoscopic Retrograde Cholangiopancreatography for Cytopathologic Diagnosis of Extrahepatic Cholangiocarcinoma

PS-05-05  /  Efficacy of ERCP-guided cytology using by a newly developed brush device with rapid on-site evaluation for a diagnosis of suspected malignant biliary strictures

PS-05-06  /  Ablative effect of endobiliary radiofrequency ablation for hilar cholangiocarcinoma: evaluation by using peroral cholangioscopy and intraductal ultrasonography

1. Introduction to the drug discovery process

2. Artificial intelligence in drug development: clinical pharmacologist perspective

3. Systems biology approaches for drug discovery and development

4. Discussion

1. Colon cancer and microbime: its use in diagnosis and risk stratification

2. Role of microbime as a biomarker in IBD

3. Recent trend in the analysis method of microbiome: Beyond 16s rRNA

4. Oral microbiota-epithelium crosstalk regulates local and distal carcinogenesis

5. Discussion

1. Gut microbiota changes in GERD: the impact of long-term proton pump inhibitor treatment

2. Helicobacter pylori and functional dyspepsia: gut microbiota alteration after H. pylori eradication

3. Probiotics in chronic constipation: where are we?

4. Fecal microbiota transplantation: current evidence in IBS treatment

5. Discussion

1. Esophageal/Stomach cancer

2. Pancreatobiliary cancer

3. Colorectal cancer

4. Neuroendocrine cancer

5. Discussion

FP-01-01  /  In-hospital morality after surgery in patients with liver cirrhosis: an analysis from HIRA-NIS of South Korea, 2012–2016

FP-01-02  /  Microbiome restoration after rifaximin treatment in patients with severe alcoholic hepatitis

FP-01-03  /  Comparison of Dexamethasone and Celecoxib for Prophylaxis for Transarterial Chemoembolization

FP-01-04  /  NK cell activity is a useful predictive factor for mortality in patients with hepatocellular carcinoma

FP-01-05  /  Surgical resection versus transarterial chemoembolization-based locoregional therapy for single hepatocellular carcinoma with minor portal vein invasion

1. The effect of female sex hormones on the sex ratio of gastric cancer

2. Development of a rehabilitation program for the prevention of musculoskeletal diseases by gastrointestinal endoscopists and evaluation of their effectiveness

3. How to apply gender innovation in medical research?

4. Discussion

FP-02-01  /  Body Weight Variability and the Risk of Cardiovascular Outcomes in Patients with Nonalcoholic Fatty Liver Disease: A Nationwide Cohort Study

FP-02-02  /  MR-based nonalcoholic steatohepatitis score for diagnosis of nonalcoholic steatohepatitis

FP-02-03  /  Efficacy and Safety of Lenvatinib Therapy for Unresectable Hepatocellular Carcinoma in a Real-World Practice in Korea

FP-02-04  /  PD-L1 expression of tumor-associated macrophages as an indicator of nivolumab response in unresectable hepatocellular carcinoma

FP-02-05  /  Surgery versus external beam radiotherapy for hepatocellular carcinoma involving the inferior vena cava or right atrium: A systematic review and meta-analysis

FP-02-06  /  Efficacy and Safety of Obeticholic Acid (Farnesoid X Receptor Agonist) in Non-alcoholic Fatty Liver Disease: Systematic Review and Meta Analysis

1. Transmission of infections that may occur in associated with endoscopic procedures

2. The essence of the endoscopic reprocessing process: things that are easy to overlook

3. Answers to questions related to endoscopic reprocessing

4. 감염증환자의 내시경감염관리 및 환경관리

5. Discussion

1. Epidemiologic trend of colon cancer: What is new?

2. Population based screening using primary colonoscopy: Holy Grail or poisoned chalice?

3. What is the best approach young age population in colon cancer screeing?

4. Old age colon cancer: How to prevent and manage?

5. Discussion

1. Virus in infectious diarrhea

2. Viral infection in inflammatory bowel disease

3. Virus and gastrointestinal cancers

4. Viral hepatitis in patients with immunosuppression

5. Discussion

PS-01-01  /  Cancer-associated fibroblast-derived fibulin-5 predicts survival in patients with diffuse-type gastric adenocarcinomas

PS-01-02  /  A Scoring Model Suggesting an Alternative Treatment to Total Gastrectomy in Proximal Early Gastric Cancer based on Nodal Metastasis Prediction

PS-01-03  /  LUCAT1 epigenetically down-regulated the tumor suppressor genes CXXC4 and SFRP2 expressions in gastric cancer

PS-01-04  /  Impact of prior cancer history on the clinical outcomes in esophageal cancer: A Propensity Score–Adjusted, Population-Based Study

PS-01-05  /  Estrogen and Helicobacter pylori CagA may induce stem cell and epithelial-mesenchymal transition phenotype in diffuse-type gastric adenocarcinomas

PS-01-06  /  The clinical outcome of 293 patients with gastric MALT lymphoma: A multi-center experience

FP-04-01  /  Association between TyG index and gastroesophageal reflux disease: a health checkup cohort study

FP-04-02  /  Impact of dietary education program on gastrointestinal symptoms in patients with functional gastrointestinal disorders: a multicenter prospective pilot study

FP-04-03  /  Combination of High Resolution Esophageal Manometry for the diagnosis of GERD

FP-04-04  /  Gender Difference in Overlap Syndrome of Irritable Bowel Syndrome and Functional Dyspepsia: A Multicenter Study in Korea

FP-04-05  /  Salbutamol Decreases Activated Colonic Mucosal Immune Reaction in Allergic Airway Disease Murine Model

1. NSAID-induced enteropathy

2. Drug induced acute pancreatitis

3. Drug induced liver injury

4. Gastrointestinal and hepatic injury of immune checkpoint inhibitors

5. Discussion

PS-02-01  /  The Prevalence and Association between GERD, Psychological Stress and Sleep Quality among Internal Medicine Resident during COVID-19 Pandemic: an-Internet-Based-Study

PS-02-02  /  The Impact of the COVID-19 pandemic on Irritable Bowel Syndrome

PS-02-03  /  Clinical characteristics, anal sphincter pressure and rectal sensations in Vietnamese patients with dyssynergic defecation on high-resolution anorectal manometry

PS-02-04  /  Effectiveness of Electrical Stimulation is associated with Regional Expression of Interstitial Cells of Cajal in Porcine Stomach

1. Updated recommendations on bowel preparation for colonoscopy

2. Efficacy and safety of novel low-volume laxatives

3. Tailored strategies for the patient's medical condition and inadequate bowel preparation

4. Optimal bowel preparation for capsule endoscopy and enteroscopy

5. Discussion

1. Up-to-date: Epidemiology of Helicobacter pylori infection and H. pylori related diseases

2. Up-to-date: Diagnosis of Helicobacter pylori infection

3. Up-to-date: Treatment of Helicobacter pylori infection

4. Up-to-date: Effect of Helicobacter pylori eradication

5. Discussion

FP-09-01  /  Fecal M2-PK & Hemoglobin As A Screening Tool In Detection Of Colorectal Carcinoma In South Asia Region - Single Surgical Unit Experience

FP-09-02  /  Evaluation of nutritional status using anthropometric measurements in patients with inflammatory bowel disease

FP-09-03  /  Application of revised PIBD classes criteria to the Korean PIBD patients.

FP-09-04  /  Efficacy and Safety of Fecal Microbiota Transplantation on Clearance of Multi-drug Resistance Organism in Multi-comorbid Patients: A prospective non-randomized comparison trial.

PS-08-01  /  Recent Trends in Incidence and Mortality of Gallbladder Cancer: a joinpoint regression analysis of data from 48 countries

PS-08-02  /  Diagnostic performance of endoscopic ultrasound-artificial intelligence using deep learning analysis of gallbladder polypoid lesions

PS-08-03  /  A Nationwide Incidence and Surgical Outcomes about Pancreatic Cysts in Korea

PS-08-04  /  Effectiveness of prophylactic antibiotics to prevent post endoscopic retrograde cholangiopancreatography bacteremia in biliary obstruction patient: a randomized, double-blind, placebo controlled study, Interim results

1. Understanding the basic techniques and devices for ESD

2. Which lesions are suitable or not suitable for colorectal ESD?

3. Tips and tricks to overcome difficult ESD

4. How to avoid and manage perforation during colorectal ESD

5. Discussion

1. Application of traditional prediction scores in patients with NVUGIB

2. Application of machine learning algorithm in the prediction of prognosis in patients with NVUGIB

3. Update on the management of NVUGIB

4. After endoscopic therapy: How to follow up

5. Discussion

1. Introduction to antithrombotics

2. Current guidelines of antithrombotics in low risk endoscopic procedure

3. Current guidelines of antithrombotics in high risk endoscopic procedure

4. Perspective of cardiologist about antithrombotics in endoscopic procedure

5. Discussion

1. How to make real leadership?

2. How to ensure quality and safety of patient care?

3. Medical ethics, why is it important?

4. Medical diversity, why is it necessary?

5. Discussion

1. Medical management for gallstones (including followup after CBD stone removal)

2. Endoscopic management for gallstones in the special situation

3. Endoscopic management of common bile duct stone

4. Surgical Treatment for bile duct stone

5. Discussion

PS-09-01  /  Facilitators and Barriers of Participation in Colorectal Cancer Screening: a qualitative study of Chinese elderly subjects

PS-09-02  /  Increasing changes in visceral adiposity is associated with higher risk for colorectal adenoma: multilevel analysis in a prospective cohort

PS-09-03  /  Vedolizumab is safe and efficacious for the treatment of pediatric-onset inflammatory bowel disease patients who fail a primary biologic agent

PS-09-04  /  Metformin Suppresses Cancer Stem Cells through AMPK Activation and Inhibition of Protein Prenylation of the Mevalonate Pathway in Colorectal Cancer

PS-09-05  /  Venous thromboembolism risk in Asian patients with inflammatory bowel disease: A population-based nationwide cohort study

1. Esophageal strictures, endoscopic approach

2. Esophageal strictures, radiologic approach

3. Gastric outlet stenosis/obstruction

4. Upper GI tract leaks

5. Discussion

1. Pathophysiology

2. Diagnostic approach

3. Medical treament

4. Korean guideline of FD

5. Discussion

1. New implication of dietary therapy in IBD

2. The effect of Biologics treatment on linear growth in IBD

3. Building a strong future : Bone health in IBD

4. Discussion

1. The approach of abnormal findings of the Ampulla of Vater

2. Endoscopic management for tumor of ampulla of Vater

3. Surgical approach for tumor of ampulla of Vater

4. Surveillance for resection of tumor of ampulla of Vater

5. Discussion